JW Lifescience Corporation (KRX:234080)
South Korea · Delayed Price · Currency is KRW 12,450
+50 (0.40%)
Last updated: May 15, 2026, 9:03 AM KST
JW Lifescience Market Cap
JW Lifescience has a market cap or net worth of 192.01 billion as of May 14, 2026. Its market cap has increased by 11.91% in one year.
Market Cap
192.01B
Enterprise Value
232.09B
Revenue
257.83B
Ranking
n/a
PE Ratio
6.71
Stock Price
12,450.00
Market Cap Chart
Since October 27, 2016, JW Lifescience's market cap has decreased from 340.05B to 192.01B, a decrease of -43.53%. That is a compound annual growth rate of -5.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 189.07B | -4.98% |
| Dec 30, 2025 | 198.98B | 18.11% |
| Dec 30, 2024 | 168.47B | -15.46% |
| Dec 28, 2023 | 199.29B | 5.93% |
| Dec 29, 2022 | 188.14B | -12.27% |
| Dec 30, 2021 | 214.46B | -34.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samjin Pharmaceuticals | 218.68B |
| Hyundai Pharmaceutical | 217.27B |
| Whan In Pharm | 211.09B |
| Daewon Pharmaceutical | 209.19B |
| Suheung | 208.69B |
| REYON Pharmaceutical | 206.34B |
| AptaBio Therapeutics | 202.83B |
| Jeil Pharmaceutical Co.,Ltd | 192.78B |